SCHEMBL1209324

SCHEMBL1209324

N#Cc1c(NC(=O)C=Cc2cccnc2)sc2c1CCC(OC(=O)N1CCC(O)CC1)C2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 3/20 0.43
MAPT P10636 6/20 0.41
LMNA P02545 3/20 0.41
GAA P10253 2/20 0.41
PTPN5 P54829 1/20 0.40
ALDH1A1 P00352 7/20 0.40
POLB P06746 5/20 0.40
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
KDM4E B2RXH2 3/20 0.40
HPGD P15428 2/20 0.40
NR0B1 P51843 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.36
TNF P01375 2/20 0.36
NOD1 Q9Y239 2/20 0.36
HTT P42858 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12895236 1.00 TGFBR1 (0.43) TGFBR1MAPTLMNAGAAPTPN5
SCHEMBL1209433 0.96 TGFBR1 (0.42) TGFBR1MAPTLMNAGAAPTPN5
SCHEMBL12895508 0.96 TGFBR1 (0.42) TGFBR1MAPTLMNAGAAPTPN5
SCHEMBL12895349 0.96 TGFBR1 (0.42) TGFBR1MAPTLMNAGAAPTPN5
SCHEMBL12895443 0.96 TGFBR1 (0.42) TGFBR1MAPTLMNAGAAPTPN5
SCHEMBL1207078 0.94 TGFBR1 (0.46) TGFBR1MAPTLMNAGAAPTPN5
SCHEMBL12895446 0.94 TGFBR1 (0.46) TGFBR1MAPTLMNAGAAPTPN5
SCHEMBL12882712 0.94 TGFBR1 (0.46) TGFBR1MAPTLMNAGAAPTPN5
SCHEMBL1208425 0.94 TGFBR1 (0.46) TGFBR1MAPTLMNAGAAPTPN5
SCHEMBL1208611 0.93 TGFBR1 (0.46) TGFBR1MAPTLMNAGAAPTPN5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110044938-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES NYCOMED GMBH (DE) 2011-02-24 US claimed
EP-2051974-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES 4SC AG (DE) 2009-04-29 EP claimed
WO-2008020045-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES 4SC AG (DE) 2008-02-21 WO claimed
US-20110044938-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES NYCOMED GMBH (DE) 2011-02-24 US disclosed
EP-2051974-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES 4SC AG (DE) 2009-04-29 EP disclosed
WO-2008020045-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES 4SC AG (DE) 2008-02-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110044938-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES BAX, BCL2, BAD TGFBR1 1167/4885MAPT 865/4885LMNA 3666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.